Articles

Results 1 to 5 of 601


Learning the Steps of the BPCIA's Patent Dance : notice of commercial marketing is mandatory

USA - September 30 2016 The Federal Circuit’s second opinion interpreting the Biologics Act in Amgen v. Apotex is dense, but the outcome is simple. There are two takeaways…

Jamie Kitano, Peter Strand

Dissatisfied patent reexamination plaintiff contends standing conferred by statute

USA - November 13 2014 A consumer-interest organization that was dissatisfied by a Board of Patent Appeals and Interferences (BPAI) ruling in the appeal of a patent…

Debra S. Dunne, Chris A. Johnson, Madeleine M. McDonough, John Simpson

Ninth Circuit rules out state’s claims in class settlement with fetal-gender testing co

USA - November 13 2014 The Ninth Circuit Court of Appeals has enjoined California's effort to obtain restitution on behalf of individual citizens bound by the bargainedfor…

Debra S. Dunne, Chris A. Johnson, Madeleine M. McDonough, John Simpson

Bio-Rad agrees to pay $55 million to resolve SEC bribery charges

USA - November 13 2014 A California-based clinical diagnostic and life science research company has reportedly agreed to pay $55 million to resolve U.S. Securities and…

Debra S. Dunne, Chris A. Johnson, Madeleine M. McDonough, John Simpson

FTC settles deceptive sales-tactics claims against MPHJ Technology

USA - November 13 2014 The U.S. Federal Trade Commission (FTC) has agreed to settle claims that MPHJ Technology Investments, LLC—a patent-assertion entity (PAE)—and company…

Debra S. Dunne, Chris A. Johnson, Madeleine M. McDonough, John Simpson